foxo4 dri senolytic FOXO4-DRI: The Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness FOXO4-DRI Vial 10mg
FOXO4 DRI Vial 10mg FOXO4 DRI 10mg Senolytic Research Peptide Kalyx Labs FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Molecular targets of senolytic drugs. Download Scientific Diagram
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 20 - Sep 25




